Search Login Register
Pancreatitis
Summary
Description:
INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.
Also Known As:
Pancreatitides
Networked: 15036
relevant articles (1006 outcomes,
2052 trials/studies)
for this Disease
Key Drugs and Agents for Pancreatitis
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Caerulein (Ceruletide)
:
99 outcomes 197 studies in 1146 results
: IBA
-
Amylases
:
75 outcomes 77 studies in 1474 results
:
FDA 1
-
Protease Inhibitors (Protease Inhibitor)
:
36 outcomes 39 studies in 200 results
: IBA
-
Gabexate (Foy)
:
34 outcomes 35 studies in 110 results
: IBA
-
Octreotide (Sandostatin)
:
33 outcomes 53 studies in 170 results
:
FDA 14
Generic
-
Somatostatin (Somatotropin Release-Inhibiting Factor)
:
32 outcomes 54 studies in 190 results
: IBA
-
Lipase (Acid Lipase)
:
32 outcomes 49 studies in 752 results
:
FDA 1
-
Anti-Bacterial Agents (Antibiotics)
:
20 outcomes 37 studies in 213 results
: IBA
-
Taurocholic Acid (Sodium Taurocholate)
:
17 outcomes 57 studies in 512 results
: IBA
-
Trypsin
:
16 outcomes 48 studies in 531 results
: IBA
Show All >>
Diseases Related to Pancreatitis
-
Pain (Aches)
-
Necrosis
-
Lung Injury
-
Gallstones (Gallstone)
-
Chronic Pancreatitis
Show All >>
Key Therapies for Pancreatitis
Efficacy Chart >>
-
Enteral Nutrition (Feeding, Tube)
:
28 outcomes 45 studies in 255 results
-
Stents
:
21 outcomes 28 studies in 317 results
-
Endoscopic Sphincterotomy
:
19 outcomes 31 studies in 303 results
-
Parenteral Nutrition
:
15 outcomes 24 studies in 141 results
-
Pancreatectomy
:
13 outcomes 6 studies in 156 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.